The antiphospholipid syndrome, recently described, associates thromboe
mbolism riks, fetal losses and thrombopenia. An obstetrical survey of
this syndrome implies previous analyses of maternal and fetal risks an
d leads to treatment which may associate low doses of aspirin, heparin
, corticoids. This complex syndrome offers the best example of materno
-fetal medecine usefulness.